Amidst news of 23andMe and Ancestry layoffs, Vox spoke with GoodCell CEO and co-founder Trevor Perry on market saturation and limited utility of existing DNA kits. As consumers look for a more holistic approach to health, GoodCell is among the companies leading the charge by providing health-conscious customers with a long-term testing and cell storage solution. This approach is enabling consumers to reap benefits beyond a one-and-done test and preparing them to take advantage of the latest medical breakthroughs.

GoodCell
LifeVault’s GoodCell Looks to Expand Personal Biobanking Business, Touts Cell Quality Monitoring
Media & Press
CHICAGO – Startup LifeVault Bio, which offers personal biobanking, small-panel genetic testing, and analysis under the GoodCell name, is trying to break new ground by creating metrics for measuring cell quality. This, company officials said, will help assure researchers and clinicians that the samples stored in the biobank will be most useful for future testing. “We want to be the gold standard behind how you measure quality of cells,” said Cofounder and CEO Trevor Perry. The Waltham, Massachusetts-based startup did not identify the investors or lender.
read more >
GoodCell
Direct-to-Consumer Biobanking Firm LifeVault Bio Raises $5.6M
Media & Press
NEW YORK – LifeVault Bio, a consumer-facing company offering personal biobanking services under the name GoodCell, said Tuesday that it has closed on $5.6 million in financing. That total includes $2.6 million in investments and a $3 million convertible note. The Waltham, Massachusetts-based startup did not identify the investors or lender.
read more >
GoodCell
GoodCell
GoodCell Oversubscribes Upon Debut
Media & Press
GoodCell helps individuals take control of their health through personalized biobanking of cells, DNA and blood plasma, with the belief that medical science will continue to progress, bringing forth new ways of preventing, detecting and treating diseases. Research continues to prove that cells are an essential starting material for the treatments of tomorrow. DNA and plasma are widely validated as critical information sources for monitoring and tracking health risk and informing lifestyle decisions. GoodCell aims to empower individuals with personal health information and storage resources to take full advantage of...
read more >
GoodCell